OTCMKTS:ARRJF Arjo AB (publ) (ARRJF) Stock Price, News & Analysis → Biden replacement revealed? (From Paradigm Press) (Ad) Free ARRJF Stock Alerts $4.59 0.00 (0.00%) (As of 05/1/2024 ET) Add Compare Share Share Today's Range$4.59▼$4.5950-Day Range$3.83▼$4.8552-Week Range$3.70▼$4.85VolumeN/AAverage Volume160 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartShort InterestStock AnalysisChartShort Interest Get Arjo AB (publ) alerts: Email Address Ad Porter & CompanyThe biggest energy story ever? Discover why I’m calling this one of the biggest developments in the global energy market since the shale revolution… why everything you’ve ever been told about Trump’s environmental record is a lie…For the full story, click here. About Arjo AB (publ) Stock (OTCMKTS:ARRJF)Arjo AB (publ) develops and sells medical devices and solutions for patients for clinical and financial outcomes for healthcare in Europe, Asia and Pacific, South America, Africa, and internationally. It offers products and solutions for patient handling, hygiene, disinfection, medical beds, pressure injury prevention, diagnostics, prevention of deep vein thrombosis and treatment of edema, leg ulcer treatment and prevention, and for obstetric and cardiac diagnostics. The company also provides dementia and bariatric room assessment solutions, prone positioning early mobility, and rehabilitation services, as well as maintenance, and equipment rental and financing solutions. It serves private and public institutions that provide acute and long-term care. Arjo AB (publ) was founded in 1957 and is headquartered in Malmö, Sweden.Read More ARRJF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart ARRJF Stock News HeadlinesApril 30, 2024 | americanbankingnews.comArjo AB (publ) (OTCMKTS:ARRJF) Sees Large Decline in Short InterestApril 21, 2024 | finanznachrichten.deArjo AB: Resolutions at Arjo's Annual General Meeting 2024May 2, 2024 | Porter & Company (Ad)Trump’s last act as President You’ve probably never heard of Executive Order #13972. Signed by President Trump just days before leaving office, it greenlit what could be the most revolutionary technology of the decade… yet it has nothing to do with AI, blockchain, or mRNA vaccines. April 19, 2024 | finance.yahoo.comArjo AB's Dividend AnalysisMarch 27, 2024 | morningstar.comArjo AB Class B ARJO BFebruary 16, 2024 | morningstar.comBonesupport Holding AB BONEXDecember 29, 2023 | ca.finance.yahoo.comArjo AB (publ) (ARJO-B.ST)November 27, 2023 | msn.comABS-CBN Launching Sales On ‘The Bagman’ Starring Arjo Atayde At Singapore’s ATFMay 2, 2024 | Porter & Company (Ad)Trump’s last act as President You’ve probably never heard of Executive Order #13972. Signed by President Trump just days before leaving office, it greenlit what could be the most revolutionary technology of the decade… yet it has nothing to do with AI, blockchain, or mRNA vaccines. November 19, 2023 | msn.comShowbiz Roundup: Arjo Atayde-Maine Mendoza’s beach trip to Carla Abellana’s credit cardSeptember 5, 2023 | wsj.comArjo AB Series BAugust 7, 2023 | msn.comHouse clarifies Arjo Atayde’s trip to EuropeSee More Headlines Receive ARRJF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Arjo AB (publ) and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Distribution Sub-IndustryN/A Current SymbolOTCMKTS:ARRJF CUSIPN/A CIKN/A Webwww.arjo.com Phone46 1 03 35 45 00FaxN/AEmployees6,500Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A 12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?Get This Free Report Key ExecutivesMr. Joacim Lindoff (Age 51)CEO, President & Director Comp: $17.05MMr. Niclas Sjosward (Age 50)Chief Financial Officer Jonas Cederhage (Age 53)Executive Vice President of Product Development, Supply Chain & Operations Sara EhingerVice President of Investor Relations & Corporate CommunicationsMs. Ingrid Carlsson (Age 48)Executive VP of Legal & Business Compliance and Board Secretary Ms. Marianne Nilsson (Age 42)Executive Vice President of Communication & Public Relations Mr. Christian Stentoft (Age 40)President of Global Sales & Service Mr. Tobias Kramer (Age 40)Executive Vice President of Global Marketing Ms. Marion Gullstrand (Age 67)Executive Vice President of Human Resources & Sustainability Ms. Katarzyna Bobrow (Age 44)Executive Vice President of Quality & Regulatory Compliance More ExecutivesKey CompetitorsAlfresaOTC:ARHCFChina MedicineOTCMKTS:CHMEEBOS GroupOTCMKTS:EBOSFGalenicaOTCMKTS:GALNFMcKesson EuropeOTCMKTS:CAKFYView All Competitors ARRJF Stock Analysis - Frequently Asked Questions How have ARRJF shares performed in 2024? Arjo AB (publ)'s stock was trading at $3.83 on January 1st, 2024. Since then, ARRJF stock has increased by 19.8% and is now trading at $4.59. View the best growth stocks for 2024 here. Are investors shorting Arjo AB (publ)? Arjo AB (publ) saw a drop in short interest in the month of April. As of April 15th, there was short interest totaling 250,400 shares, a drop of 5.2% from the March 31st total of 264,000 shares. Based on an average daily volume of 0 shares, the days-to-cover ratio is currently ∞ days. View Arjo AB (publ)'s Short Interest. How do I buy shares of Arjo AB (publ)? Shares of ARRJF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:ARRJF) was last updated on 5/2/2024 by MarketBeat.com Staff From Our Partners😱 This phenomenon is smashing regular market gainsMillPubBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldHave You Seen Elon’s New A.I. Device? (Picture Inside)InvestorPlaceA.I. is a Tidal Wave - Here’s What to BuyChaikin AnalyticsYour bank is lying to you.MyBankTrackerDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsPOTUS in ‘25 Not Biden/Trump, ButThe Freeport SocietyForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill Publishing Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Arjo AB (publ) Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.